|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Net Loss | |||||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation expense | |||||
| Change in value of Series B Warrants | |||||
| Change in value warrants, senior convertible note | |||||
| Change in value of senior warrants, loss | |||||
| Change in value of conversion feature senior notes, (gain) | |||||
| Change in value warrants, senior convertible notes | |||||
| Debt discount amortization expense | |||||
| Interest accrued, senior convertible notes paid in common stock | |||||
| Debt discount amortization expense on subordinated note | |||||
| Accrued interest Subordinated Notes paid in stock | |||||
| Extinguishment loss on senior notes conversions | |||||
| Extinguishment loss on subordinated notes | |||||
| Derivative revaluations (gain) loss | |||||
| Impairment of assets, net | |||||
| Allowance for doubtful accounts | |||||
| Amortization deferred finance costs | |||||
| Net (gain) on sale of assets | |||||
| Warrants issued for placement agent fees | |||||
| Placement agent warrants | |||||
| Stock-based compensation expense | |||||
| Inventory valuation adjustment | |||||
| Loss on impairment of property and equipment | |||||
| Loss on impairment of other assets | |||||
| Changes in operating assets & liabilities | |||||
| Accounts receivable, net | |||||
| Other current assets | |||||
| Inventory | |||||
| Accounts payable | |||||
| Other current liabilities | |||||
| Accrued interest | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Other receivables | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Other receivables | |||||
| Proceeds from sale of assets | |||||
| Capital expenditures | |||||
| Net cash (used in) investing activities | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Repayment of notes payable | |||||
| Proceeds from senior convertible notes | |||||
| Repayment of senior convertible notes | |||||
| Proceeds from convertible debt | |||||
| Repayment of bridge loan | |||||
| Gross proceeds from sale of common stock | |||||
| Repayment of subordinated convertible note | |||||
| Gross proceeds from warrant exercise | |||||
| Payment of public offering and debt issuance costs | |||||
| Amount provided from (deposited into) restricted cash account | |||||
| Net cash provided by financing activities | |||||
| Net decrease in Cash and Cash Equivalents | |||||
| Effect of exchange rate on cash | |||||
| Cash and Cash Equivalents, Beginning of Year | |||||
| Cash and Cash Equivalents, End of Year | |||||
| Supplemental schedule of Cash Flow Information: | |||||
| Warrants issued for placement agent fees | |||||
| Cash paid for interest | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Interest accrued converted into debt principal | |||||
| Common stock issued for principal payments on senior notes | |||||
| Conversion of senior convertible note warrants | |||||
| Issuance of Series B warrants | |||||
| Common stock issued for interest and make whole payment on senior notes | |||||
| Common stock issued to settle liability | |||||
| Reclassification of remaining bridge note to notes payable | |||||
| Common stock issues in exchange for senior warrants | |||||
| Common stock issued for warrants exercised | |||||
| Reclassification of derivative liability for warrants exercised | |||||
| Beneficial conversion feature related to convertible bridge notes | |||||
| Debt discount related to convertible bridge notes | |||||
| Accounts payables converted into promissory note | |||||
| Round up shares | |||||
| Derivative liability related to 2015 senior convertible notes at issuance | |||||
| Offering costs | |||||
Loading...